Over the past 5 years, breakthroughs in the delivery of systemic therapy have transformed advanced hepatocellular carcinoma, a disease with a typical life expectancy of 6 months following diagnosis...
Pinato, D.J., D'Alessio, A., Celsa, C., Manfredi, G.F., Fulgenzi, C.A.M. (2023). The price and value of therapeutic synergy in liver cancer. THE LANCET, 402(10408), 1108-1110 [10.1016/S0140-6736(23)01297-7].
The price and value of therapeutic synergy in liver cancer
Celsa, CiroPrimo
;
2023-09-30
Abstract
Over the past 5 years, breakthroughs in the delivery of systemic therapy have transformed advanced hepatocellular carcinoma, a disease with a typical life expectancy of 6 months following diagnosis...
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0140673623012977-main.pdf
Solo gestori archvio
Descrizione: articolo principale
Tipologia:
Versione Editoriale
Dimensione
368.01 kB
Formato
Adobe PDF
|
368.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
